Hyperhomocysteinemia
Hyperhomocysteinemia is a medical condition characterized by an abnormally high level of total homocysteine in the blood, conventionally described as above 15 μmol/L.
As a consequence of the biochemical reactions in which homocysteine is involved, deficiencies of
vitamin B6, folic acid, and vitamin B12 can lead to high homocysteine levels. Other possible causes of hyperhomocysteinemia include genetics, excessive methionine intake, and other diseases.
Hyperhomocysteinemia is typically managed with vitamin B6, vitamin B9 and vitamin B12 supplementation. Hyperhomocysteinemia is a risk factor for cardiovascular disease; supplements of these vitamins may slightly reduce stroke outcome but not myocardial infarction, death from any cause or adverse events.
Signs and symptoms
Elevated levels of homocysteine have been associated with a number of disease states: more than 100 adverse outcomes have been identified.Cardiovascular risks
Elevated homocysteine is a known risk factor for cardiovascular disease as well as thrombosis. It has also been shown to be associated with microalbuminuria which is a strong indicator of the risk of future cardiovascular disease and renal dysfunction. Homocysteine degrades and inhibits the formation of the three main structural components of arteries: collagen, elastin and proteoglycans. In proteins, homocysteine permanently degrades cysteine disulfide bridges and lysine amino acid residues, affecting structure and function.Neuropsychiatric illness
Evidence exists linking elevated homocysteine levels with vascular dementia and Alzheimer's disease. There is also evidence that elevated homocysteine levels and low levels of vitamin B6 and B12 are risk factors for mild cognitive impairment and dementia. Oxidative stress induced by homocysteine may also play a role in schizophrenia.Bone health
Elevated levels of homocysteine have also been linked to increased fractures in elderly persons. Homocysteine auto-oxidizes and reacts with reactive oxygen intermediates, damaging endothelial cells and increasing the risk of thrombus formation.Ectopia lentis
is the second most common cause of heritable ectopia lentis. Homocystinuria is an autosomal recessive metabolic disorder most often caused by a near absence of cystathionine b-synthetase. It is associated with intellectual disability, osteoporosis, chest deformities, and increased risk of thrombotic episodes. Lens dislocation occurs in 90% of patients, and is thought to be due to decreased zonular integrity due to the enzymatic defect. Lens dislocation in homocystinuria is usually bilateral and in 60% of cases occurs in the inferior or nasal direction.Possible causes
B-enzyme deficiencies
A number of factors have been considered as causes of high homocysteine levels. Deficiencies of vitamins B6, B9 and B12 have been implicated. Vitamin B12 is a cofactor for the enzyme methionine synthase, which participates in the biosynthesis of S-adenosylmethionine. Vitamin B12 deficiency prevents the 5-methyltetrahydrofolate form of folate from being converted into THF due to the "methyl trap". This disrupts the folate pathway and leads to an increase in homocysteine which damages cells.Alcohol
Chronic consumption of alcohol may also result in increased plasma levels of homocysteine.Tobacco
Smokeless tobacco may be a risk factor for hyperhomocysteinemia.Genetic
Genetic defects in 5-MTHF reductase can lead to hyperhomocysteinemia. The most common polymorphisms are known as MTHFR C677T and MTR A2756G. The homozigote mutation G;G also called C;C occurs in about 10% of the population of european ethnicity. Elevations of homocysteine can also occur in the rare hereditary disease homocystinuria.Diagnosis
A blood test can be performed to quantify total homocysteine concentration in the plasma, of which approximately 80% is generally protein-bound. Classification of hyperhomocysteinemia is defined with respect to serum concentration as follows:- Moderate: 15–30 nmol/mL
- Intermediate: 30–100 nmol/mL
- Severe: > 100 nmol/mL